Search research articles
Contact Us
Filters
Showing results (121-130 of 130) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 130 results.
Alzheimer'S Research & Therapy
|
October 26, 2018
FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer's disease
Petr Novak, Reinhold Schmidt, Eva Kontsekova, et al.
The Lancet. Neurology
|
December 14, 2016
Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial
Petr Novak, Reinhold Schmidt, Eva Kontsekova, et al.
Nature Genetics
|
March 24, 2026
Author Correction: Allelic variation at a single locus distinguishes spring and winter faba beans
Hailin Zhang, Alex Windhorst, Elesandro Bornhofen, et al.
Nature Methods
|
May 14, 2026
Recommendations and considerations for hydroxyl radical protein footprinting-mass spectrometry
Aaron T Wecksler, Lingfei Wang, Lisa J Bernstein, et al.
Nature Genetics
|
March 11, 2026
Allelic variation at a single locus distinguishes spring and winter faba beans
Hailin Zhang, Alex Windhorst, Elesandro Bornhofen, et al.
F1000Research
|
July 18, 2017
A community proposal to integrate proteomics activities in ELIXIR
Juan Antonio Vizcaíno, Mathias Walzer, Rafael C Jiménez, et al.
Cell
|
August 4, 2022
Repeat-based holocentromeres influence genome architecture and karyotype evolution
Paulo G Hofstatter, Gokilavani Thangavel, Thomas Lux, et al.
The Journal of Allergy and Clinical Immunology
|
September 18, 2021
Early-onset pulmonary and cutaneous vasculitis driven by constitutively active SRC-family kinase HCK
Veronika Kanderova, Tamara Svobodova, Simon Borna, et al.
Nature Aging
|
April 28, 2023
ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease
Petr Novak, Branislav Kovacech, Stanislav Katina, et al.
Structure (London, England : 1993)
|
October 16, 2020
Toward Increased Reliability, Transparency, and Accessibility in Cross-linking Mass Spectrometry
Alexander Leitner, Alexandre M J J Bonvin, Christoph H Borchers, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 130) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 130 results.
Alzheimer'S Research & Therapy
|
October 26, 2018
FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer's disease
Petr Novak, Reinhold Schmidt, Eva Kontsekova, et al.
The Lancet. Neurology
|
December 14, 2016
Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial
Petr Novak, Reinhold Schmidt, Eva Kontsekova, et al.
Nature Genetics
|
March 24, 2026
Author Correction: Allelic variation at a single locus distinguishes spring and winter faba beans
Hailin Zhang, Alex Windhorst, Elesandro Bornhofen, et al.
Nature Methods
|
May 14, 2026
Recommendations and considerations for hydroxyl radical protein footprinting-mass spectrometry
Aaron T Wecksler, Lingfei Wang, Lisa J Bernstein, et al.
Nature Genetics
|
March 11, 2026
Allelic variation at a single locus distinguishes spring and winter faba beans
Hailin Zhang, Alex Windhorst, Elesandro Bornhofen, et al.
F1000Research
|
July 18, 2017
A community proposal to integrate proteomics activities in ELIXIR
Juan Antonio Vizcaíno, Mathias Walzer, Rafael C Jiménez, et al.
Cell
|
August 4, 2022
Repeat-based holocentromeres influence genome architecture and karyotype evolution
Paulo G Hofstatter, Gokilavani Thangavel, Thomas Lux, et al.
The Journal of Allergy and Clinical Immunology
|
September 18, 2021
Early-onset pulmonary and cutaneous vasculitis driven by constitutively active SRC-family kinase HCK
Veronika Kanderova, Tamara Svobodova, Simon Borna, et al.
Nature Aging
|
April 28, 2023
ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease
Petr Novak, Branislav Kovacech, Stanislav Katina, et al.
Structure (London, England : 1993)
|
October 16, 2020
Toward Increased Reliability, Transparency, and Accessibility in Cross-linking Mass Spectrometry
Alexander Leitner, Alexandre M J J Bonvin, Christoph H Borchers, et al.
Page
of 13